Use of GPR119 receptor agonists for increasing bone mass and for treating osteoporosis, and combination therapy relating thereto

Details for Australian Patent Application No. 2007238728 (hide)

Owner Arena Pharmaceuticals, Inc.

Inventors Chu, Zhi-Liang; Jones, Robert M.; Lehmann, Juerg; Leonard, James N.

Agent FB Rice

Pub. Number AU-A-2007238728

PCT Pub. Number WO2007/120702

Priority 60/791,613 11.04.06 US; 60/851,244 12.10.06 US; 60/834,737 31.07.06 US

Filing date 10 April 2007

Wipo publication date 25 October 2007

International Classifications

A61K 31/00 (2006.01)

A61K 31/4375 (2006.01)

A61K 31/4439 (2006.01)

A61K 31/4545 (2006.01)

A61K 31/505 (2006.01) - Pyrimidines

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61K 31/522 (2006.01)

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 19/08 (2006.01) Drugs for skeletal disorders

A61P 19/10 (2006.01) Drugs for skeletal disorders

Event Publications

9 October 2008 PCT application entered the National Phase

  PCT publication WO2007/120702 Priority application(s): WO2007/120702

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007238732-Herbicidal mixtures

2007238723-Process monitoring technique and related actions